Committed to developing innovative solutions
Silo Pharma, Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. We are committed to developing innovative solutions to address a variety of underserved conditions.
The Silo difference
We are committed to developing innovative solutions to address a variety of underserved conditions including Alzheimer’s; Multiple Sclerosis (MS); Rheumatoid Arthritis (RA); Fibromyalgia; and Stress-Induced Psychiatric Disorders.
While partnering with some of the leading Academic Institutions Silo has licensed therapeutics that will allow the company to pursue the more streamlined 505(b)(2) route for trials.
Silo anticipates this strategy will lower cost and allow for a faster approval process to help patients with few if any proven addressable therapeutics.